TB screening

1. Centers for Disease Control and Prevention. (2005, December 30). Guidelines for Preventing the Transmission of Mycobacterium Tuberculosis in Health-Care Settings. 54(RR-17). 1-141. http://www.cdc.gov/mmwr/preview/mmwrhtml/rr5417a1.htm
2. Centers for Disease Control and Prevention. Updated guidelines for using interferon-gamma release assays to detect Mycobacterium tuberculosis infection – United States, 2010. MMWR 2010: 59 (No. RR-5). http://www.cdc.gov/mmwr/preview/mmwrhtml/rr5905a1.htm?_cid=rr5905a1_e
3. Sosa LE, Njie GJ, Lobato MN, et al. Tuberculosis Screening, Testing, and Treatment of U.S. Health Care Personnel: Recommendations from the National Tuberculosis Controllers Association and CDC, 2019. MMWR Morb Mortal Wkly Rep 2019;68:439–443. DOI: http://dx.doi.org/10.15585/mmwr.mm6819a3
4. Thanassi, W., Behrman, A.J. Reves, R, Russi, M., Swift, M., Warkentin, J. Miyakawa, R., Wegener, D., Budnick, L., Murray, E., Scarpita, A., Hurst, B. J., Foster-Chang, S., Mathew, T., Gruden, M.A., Higashi, J. & Hudson III, T. W.  (2020).  ACOEM guidance statement: Tuberculosis screening, testing, and treatment of US health care personnel. JOEM 62(7), e355-e369. https://acoem.org/acoem/media/PDF-Library/Publications/Tuberculosis_Screening,_Testing,_and_Treatment.pdf